Abstract | The main forms of childhood malnutrition occur predominantly in children <5 years of age living in low-income and middle-income countries and include stunting, wasting and kwashiorkor, of which severe wasting and kwashiorkor are commonly referred to as severe acute malnutrition. Here, we use the term 'severe malnutrition' to describe these conditions to better reflect the contributions of chronic poverty, poor living conditions with pervasive deficits in sanitation and hygiene, a high prevalence of infectious diseases and environmental insults, food insecurity, poor maternal and fetal nutritional status and suboptimal nutritional intake in infancy and early childhood. Children with severe malnutrition have an increased risk of serious illness and death, primarily from acute infectious diseases. International growth standards are used for the diagnosis of severe malnutrition and provide therapeutic end points. The early detection of severe wasting and kwashiorkor and outpatient therapy for these conditions using ready-to-use therapeutic foods form the cornerstone of modern therapy, and only a small percentage of children require inpatient care. However, the normalization of physiological and metabolic functions in children with malnutrition is challenging, and children remain at high risk of relapse and death. Further research is urgently needed to improve our understanding of the pathophysiology of severe malnutrition, especially the mechanisms causing kwashiorkor, and to develop new interventions for prevention and treatment.
1
". Several forms of malnutrition are recognized, including stunt ing, which is characterized by reduced linear growth, wasting (including moderate wasting and severe wast ing, also known as marasmus), which is characterized by low body tissue mass and other physiological abnor malities (FIG. 1) , and kwashiorkor, which is characterized by diffuse peripheral oedema. The current classification of malnutrition is based on body size or the presence of oedema, which does not indicate the aetiology or pre cise nutritional deficits in an individual. Accordingly, this classification can effectively screen and identify mal nutrition, but it does not address each and every specific nutrient deficiency a child might have or the bio logical variability among children. Such differences have no effect on current empirical management strategies that aim to address the predominant macronutrient and micronutrient deficiencies and treat possible infections.
The term 'severe acute malnutrition' has replaced 'protein-energy malnutrition' , which was used to describe children with severe wasting and kwashiorkor (also known as nutritional oedema). In this Primer, we focus on and use the composite term 'severe malnutrition' to refer to severe wasting and kwashiorkor and to better reflect the longstanding nature of the combined infectious and environmental insults that can occur in such cases. It is important to emphasize the multi factorial aetiology of severe malnutrition and its strong association with mortality 2 , as well as the frequent co existence of different types of malnutrition in the same child over time 3 and that such concurrence further exacerbates mortality 4 . Indeed, most children with severe wasting or kwashior kor are also stunted [5] [6] [7] [8] [9] . In addition, we concentrate on the largest and most vulnerable group, children <5 years of age, reflecting SDGs Goal 2.2, which aims to "…by 2030 end all forms of malnutrition, including achieving by 2025 the inter nationally agreed targets on stunting and wasting in children under five years of age… 1 ". Other populations can be malnourished, such as pregnant women (which has implications for fetal growth) 10 , elderly individ uals 11, 12 and those with disabilities 13, 14 , but discussing these populations is beyond the scope of this Primer.
Epidemiology
Regions with a high prevalence of severe malnutrition often also have high childhood mortality, with under lying malnutrition having a major role in the risk of death.
The global estimates of the prevalence of severe mal nutrition vary between agencies and according to the methodology used
.
Commonly used figures are from the WHO, UNICEF and World Bank Group Interagency estimates, which provide both levels and trends for child growth and mal nutrition 15 and are based on standard anthropometric indices. An estimated 155 million children <5 years of age were stunted in 2016, and 52 million were wasted, of whom 17 million were severely wasted 15 . The global burden of kwashiorkor remains uncertain due to its wide geographical variability and the failure to include assess ments of oedema in most large nutritional surveys 16 ; however some estimates from regions of southern and eastern Africa suggest that kwashiorkor accounts for 50-70% of cases of severe malnutrition 5 . Geographical variations in the prevalence of severe malnutrition have been observed (FIG. 2) , which probably reflects differ ences in the distribution, causes and effects of multiple risk factors for malnutrition. These risk factors include social and environmental factors (such as poverty, poor education, limited health care access and contaminated environments) [17] [18] [19] [20] and living in areas with a high burden of infectious diseases, such as respiratory tract infec tions, diarrhoeal diseases 21 , HIV and turberculosis 19, 22 . Other risks include dietary factors, such as acute and chronic food insecurity 23 , as occurs during famines, as well as suboptimal breastfeeding and suboptimal complementary feeding practices 24 . The other major global metrics initiative, the Global Burden of Disease study, estimates the number of deaths and disabilities directly related to proteinenergy malnutrition. The 2015 Global Burden of Disease Study reported a global decline in the preva lence of severe malnutrition from 25.4 million in 1990 to 22.4 million in 2015 (REF. 25 ). However, 1990 might have represented a peak compared with previous years, during which figures were uncertain and HIV was less prevalent. This influence is especially relevant for Sub Saharan Africa, where HIV and severe malnutrition are strongly linked 22 . The 2015 Global Burden of Disease Study also reported that 174,000 deaths among children <5 years of age were directly due to protein-energy malnutrition 25 . Indeed, malnutrition, especially severe malnutrition, is associated with a high risk of death. The latest Lancet Nutrition series (published in 2013) estimated that 875,000 deaths were attributable to wasting (which was the cause of death of 12.6% of children <5 years of age), and 516,000 deaths were related to severe wasting (which was the cause of death of 7.4% of children <5 years of age) 2 . In ten longitudinal studies including ~54,000 childyears of followup and 1,300 deaths in children <5 years of age, all degrees of stunting, wasting and underweight were associated with an increased risk of death 4 . Mortality is higher in children with both wasting and stunting (who have a mortality hazard ratio (HR) of 12.3) than in those who have either wasting or stunt ing (a mortality HR of 2.3 for those with wasting only) 4 . The causes of death in individuals with mal nutrition include infectious diseases (such as diarrhoeal dis eases, pneumonia, measles and malaria) and metabolic disturb ances (such as hypoglycaemia and refeeding syn drome (see Management)) 26, 27 . 
Mechanisms/pathophysiology

Determinants of severe malnutrition
The loss of muscle and fat tissue that characterizes wast ing can be caused by inadequate protein and energy intake resulting from food insecurity, poor diet and disease. However, severe malnutrition is rarely caused by a single factor and generally arises from an inter play between social, political and economic factors, the presence of chronic infections and inflammation (both in the gut and systemically). In some circumstances, gender issues, such as a lack of female empowerment, are important drivers of malnutrition 28 . Children with severe malnutrition are common in conditions of popu lation displacement, conflict and food shortage 29 , which worsens the effects of many of the risk factors for malnutrition and are associated with ineffective remedial strategies.
During shortterm starvation (that is, up to several days of fasting), free fatty acids (FFAs) and ketone bodies are primar ily oxidized using available fat stores from adipose tissue, and myofibrillar proteins can be broken down into amino acids, which can be converted into glucose (through gluconeogenesis). After several days of starv ation (when body fat has been depleted), myo fibrillar proteins are extensively broken down to maintain essen tial metabolic processes. The shortterm regulation of macronutrient oxidation and synthesis depends on insu lin and glucagon, whereas the longterm regulation of these processes is mediated by other hormones, such as growth hormone, thyroid hormones, catecholamines and corticosteroids.
In addition, cytokine release in cachexia, especially the release of tumour necrosis factor (TNF), IL1 and IL6, can negatively influence body composition through a reduction in appetite and food intake, and direct cata bolic effects on skeletal muscle and adipose tissue 32, 33 . Increased activation of the ubiquitin-proteasome path way is the main process that degrades myo fibrillar pro teins in cachectic conditions 31, 34 . Autophagy has also been implicated in muscle wasting 31 and on going auto phagy can be detrimental for muscle cells by removing cellular components important for muscle metabolism and contraction, such as mitochondria. However, the specific roles of inflammation, proteasomes and auto phagy in severe wasting in children in lowincome and middleincome countries have not been studied in detail.
Kwashiorkor. Despite longstanding knowledge of kwashiorkor, the underlying pathophysiological mech anisms are poorly understood. In her earliest report, Cecily Williams documented that children with kwash iorkor in Ghana were fed mostly a monotonous corn diet that was deficient in essential amino acids such as lysine and tryptophan 35 . However, few studies have identified any specific nutritional deficiencies associated with the development of kwashiorkor, and studies typically have not revealed major differences in food group intake between children who developed kwashiorkor compared with those who did not or with those who developed wasting 36, 37 . Despite numerous hypotheses, the aetio logy of oedema, which is the hallmark of kwashiorkor, remains undefined. In animal models, some features of kwashiorkor, such as hypoalbuminaemia, can be induced by a diet low in protein and high in mono saccharides and disaccharides 38, 39 , but oedema is rarely observed. In addition, the degree of hypoalbuminaemia and recovery upon nutritional management in children with kwashiorkor correlates poorly with the degree of oedema or the speed of its resolution 40 . Thus, controv ersy remains regarding the contribution of factors other than hypoalbuminaemia to the development of oedema in individuals with kwashiorkor 38, 41 .
Infections. Children with severe malnutrition are highly susceptible to lifethreatening infections 2, 42 , which is a consequence of a secondary immunodeficiency. Indeed, the presentation of children with severe malnutrition to medical services might be due to a serious infection rather than the presence of malnutrition alone. Several potential mechanisms of immune dysfunction exist in individuals with malnutrition 43, 44 . Skin, respiratory and gastrointestinal mucosal barrier integrity are often impaired in children with mal nutrition, and the effects of this impairment are com pounded by chronic subclinical enteric dysfunction in close associ ation with alterations to gut microbiota 45, 46 . Children with severe malnutrition have increased levels of markers of systemic immune activation, such as the proinflammatory cytokines TNF, IL1, IL6 and IL12, which alter the growth hormone-insulinlike growth factor 1 (IGF1) axis and result in wasting and linear growth failure. Alterations in this axis are also observed in other childhood inflammatory conditions, such as juvenile arthritis and inflammatory bowel disease 47 . Systemic immune activation in severe malnutrition can be caused by acute and chronic infection, inflammatory enteropathy, translocation of microbial components from the gut lumen or mucosa into the circulation 48, 49 and dysregulated immune responses 50 .
Other alterations in the immune system in severe malnutrition include T cell dysfunction and reductions in neutrophil microbicidal activity 51 , the number of dendritic cells, antigen priming and presentation 52 and protein levels in the complement cascade 44 . Thymic atrophy, T cell hyporesponsiveness and impaired T cell prolifer ation could result from chronic immune activ ation and/or the metabolic demands of T cells for glu cose, amino acids and nutritionally mediated regulatory Nature Reviews | Disease Primers hormones, such as leptin 50, 53, 54 . Although some abnor malities in the immune system can resolve with nutri tional rehabilitation 55 , the reversal of susceptibility to infection and reduction in immune activation have not been well characterized.
Altered metabolism.
Severe malnutrition can also affect many aspects of macronutrient metabolism and endocrine function 56, 57 (FIG. 3) . In contrast to severe wast ing, which is associated with a starvationinduced response of subcutaneous fat loss and muscle wasting, kwashiorkor has been speculated to be associated with a maladaptive metabolic response; a highcarbohydrate, lowprotein diet is thought to lead to a continuous glyco lytic response and protein catabolism that is inadequate to meet the amino acid requirements necessary to main tain essential protein synthesis pathways 58 . Indeed, pro tein breakdown has been shown to be lower in children with kwashiorkor than in children with severe wasting and in those in a recovered state 59, 60 . In addition, reduced concentrations of essential and some nonessential amino acids have been reported, and these deficits were even more pronounced in children with kwashiorkor 61 . Lipid metabolism is also differentially affected in kwashiorkor and severe wasting. Adipocyte lipolysis is a tightly regulated process, with a central role for insu lin in inhibiting hormonesensitive lipase. Lipolysis is stimu lated during starvation (that is, when insulin levels are low) 62, 63 , and lipolysis has been shown to be increased in a small cohort of children with severe malnutrition compared with a control cohort 62 . However, another study did not show elevated lipolysis in children with severe malnutrition at hospital admission compared with those in a state of nutritional recovery, although reduced FFA (palmitate) flux and oxidation were noted in children with kwashiorkor compared with children with severe wasting 63 . One caveat of this study is that lipolysis was assessed when children were in the semi fasted state, when insulin levels were likely low and lipolysis was stimulated. Thus, how lipolysis is altered in the postprandial state is unknown. A recent study identified high acylcarnitine levels in the early period of hospital admission for severe malnutrition regardless of the presence of oedema, suggesting preferential fatty acid oxidation 64 . Glucose homeostasis is also disrupted in children with severe malnutrition; hypoglycaemia is common, although frequent or continuous glucose measurement studies have not yet been carried out to characterize this fully 56, 65 . Kwashiorkor is associated with reduced endo genous glucose production compared with prod uction in children with severe wasting or in healthy children, likely contributing to the development of hypo glycaemia 66 . This finding is consistent with the hypoth esis that kwashiorkor is associated with a maladaptive metabolic response 58 . In addition, glucose clearance from the blood and uptake by tissues, which is regulated by insulin, are affected; several studies have reported impaired glucose clearance in both kwashiorkor and severe wasting [67] [68] [69] . A striking feature that seems to con tribute to impaired glucose clearance is the blunted pan creatic endocrine response, with insulin sensitivity likely unaffected 67 . However, despite the reports of impaired glucose clearance in metabolic studies, hyperglycae mia has not been specifically reported in children with severe malnutrition (likely due to glucose levels usually being checked only when patients are symptomatic for hypoglycaemia), and its prevalence is unknown.
The mechanisms of impaired pancreatic function in children with severe malnutrition are poorly under stood, but studies in preclinical models have impli cated a morepolarized membrane potential, changes in cAMPdependent protein kinase catalytic subunitα protein levels and a reduced ability to increase intra cellular Ca 2+ levels in response to glucose [70] [71] [72] . In addi tion, no clear data are available regarding the pancreatic glucagon response (which is responsible for stimulat ing glucose production) in children with severe mal nutrition. Glucagon concentrations have been reported to be either mildly reduced during the acute phase of malnutrition compared with levels at recovery or ele vated in children with severe wasting compared with controls 66, 73 , but stimulation tests or systematic glucagon response measurements during hypoglycaemia have not been carried out.
In general, cortisol levels in children with severe mal nutrition are similar to levels in children without malnutri tion or are increased, which is likely related to stress and indicates that the hypothalamic-pituitaryadrenal axis is preserved in children with severe malnutrition and is probably not responsible for the development of hypoglycaemia 64, 74, 75 . Most studies have
Box 1 | Estimating the epidemiology of malnutrition
Global data regarding the epidemiology of malnutrition must be understood with reference to methodological challenges and contextual factors. For example, wasting is often highly seasonal, and the number of cases peaks around the time of pre-harvest rains, when food is scarce and the burden of infectious diseases increases (for example, a higher prevalence of malaria and diarrhoeal diseases). In many instances, the interface of food insecurity (that is, a lack of access to a sufficient quantity of affordable, nutritious food), population displacement and drought also produce the conditions leading to famine.
In addition, although prevalence estimates from cross-sectional surveys are suitable for slowly changing conditions such as stunting, they are not suitable for capturing the rapidly changing nature of severe and moderate malnutrition, which have a fairly acute onset and rapid resolution. Malnutrition can also recur, which can be unrecorded or without contact with health services at each episode. Accordingly, incidence is the most informative epidemiological measure of acute malnutrition 220 , but it is rarely well documented owing to difficulties in ascertainment 221 . Addressing this limitation, prevalence-to-incidence conversion factors are sometimes used to determine the incidence of malnutrition, especially to estimate caseloads to plan treatment services 222 . Efforts are underway to improve surveillance systems for severe malnutrition.
The problems with the measurements used to diagnose malnutrition in surveys can also affect epidemiological estimates. For example, mid-upper arm circumference (MUAC) and the presence of oedema, which are both case-defining criteria, are not measured in many field surveys, resulting in underestimates of prevalence as these criteria do not necessarily overlap with those of wasting, which is defined on the basis of low weightfor-length measures 223, 224 . Even when included, the presence of oedema might be missed in rapid surveys undertaken by poorly trained surveyors 16 . Finally, infants <6 months of age with malnutrition might be missed in epidemiological surveys, either by design or because MUAC standards for this age group have not been established. Whether surveys of malnutrition in children <5 years of age include infants <6 months of age is not always clear.
shown a reduction in thyroid function in children with severe malnutrition, but the clinical relevance of this remains unclear 76, 77 . In addition, leptin concentrations are low in children with severe malnutrition, reflecting the extent of adipose tissue loss. Leptin has a direct role in immune function, metabolism and appetite regulation, and its levels are inversely associated with mortality 64 .
Oxidative stress. Oxidative stress has also been associ ated with severe malnutrition and, in particular, with kwashiorkor. Indeed, children with severe malnutrition have reduced levels of antioxidants, including vitamin E and glutathione, compared with children without mal nutrition, and this reduction is more pronounced in children with kwashiorkor [78] [79] [80] [81] [82] . Although a reduced intake of antioxidants likely contributes to the lower levels observed in children with malnutrition, this is also likely, in part, related to a reduced synthesis of certain antioxidants, such as glutathione 59 . An imbal ance between levels of reactive oxygen species and anti oxidants has been postulated to have a role in the pathophysiology of kwashiorkor 80 , although a large randomized trial of an antioxidant mixture (containing riboflavin, vitamin E, selenium and Nacetylcysteine) in Malawi failed to show decreased rates of kwashiorkor 83 , despite a pilot study suggesting a potential beneficial treatment effect 78 . An imbalance between reactive oxy gen species production and detoxification by peroxi somes results in mitochondrial damage, which ultimately reduces ATP production and impairs cellular function in the liver. Mitochondrial dysfunction and ATP deple tion together with specific nutrient deficiencies might influence the response to an intercurrent infection and contribute to the development of multiorgan failure [84] [85] [86] [87] ; this process needs further characterization.
Cardiac function and haemodynamics. Cohort studies of small numbers of children with severe malnutrition have reported cardiac muscle atrophy and decreased cardiac output 88 , especially in children with kwashior kor 89 . However, other studies have reported a normal cardiac output when corrected for body surface area 90, 91 , with impairments observed only in the most severely ill children, which was probably related to sepsis. The largest study to date excluded severely ill children and showed no major differences in cardiac function between hospitalized children with severe malnutrition and children without malnutrition at an average of 4 days after admission 91 . The mechanisms leading to cardiac atrophy have not been well studied, although one study used a mouse model of calorie restriction to show that this was related to a proportional decrease in different subcellular components of cardiomyocytes 92 .
Hepatic function. Severe malnutrition, in particular kwashiorkor, is associated with changes in hepatic meta bolic function. A striking feature of kwashiorkor is the presence of hepatic steatosis (that is, fatty liver) 35 . One study suggested that the hepatic steatosis in kwashiorkor is not related to the impaired secretion of lipids (in the form of very lowdensity lipoproteins) by the liver 93 . In addition, an increase in fatty acid release from adi pose tissue that could be taken up by the liver has been observed in children with kwashiorkor in some 62, 94 , but not all 63 , studies, which might be related to whether the analyses were performed when the participants were in the fasted state. Impaired hepatic lipid oxidation might also explain the hepatic steatosis observed in children with kwashiorkor 63 . This lipid oxidation is difficult to assess in children, but some data from postmortem samples and animal models suggest that mitochondrial function, which is mainly responsible for hepatic lipid oxidation, is impaired 66, 84, 95, 96 . Indeed, impaired mito chondrial function would be expected to affect hepatic synthetic pathways, and reduced glucose synthesis in children with kwashiorkor was shown to be correlated with mitochondrial activity 66 . Other alterations in the livers of children with kwashiorkor include reduced albumin synthesis 97 , although whether other hepatic syn thetic processes (such as the production of coagulation factors) are altered has not been studied.
Enteropathy.
Although much interest surrounds the potential association of stunting with enteropathy 98 , intestinal dysfunction also accompanies severe mal nutrition. Indeed, diarrhoea is common in children with malnutrition and is associated with poor clin ical outcomes [99] [100] [101] . Several factors might contribute to secretory and osmotic diarrhoea in individuals with malnutrition, including intestinal infections and inflam mation 102 . In addition, poor nutrient digestion resulting from impaired hepatobiliary and pancreatic exocrine function could contribute to nutrient malabsorption and diarrhoea [103] [104] [105] [106] . Malnutrition leads to small intesti nal villous blunting, thereby reducing intestinal absorp tive capacity, including impaired monosaccharide and disaccharide absorption, which could contribute to osmotic diarrhoea 107 . Children with severe malnutrition have distinct alterations in their intestinal microbiota that can affect intestinal inflammation and function, as well as the growth of the child 108 . In addition, the faecal microbiota of children with kwashiorkor in Malawi was immature, with a reduced diversity, compared with the microbiota of their twins without malnutrition 109 . Interestingly, mice that received transplantation of the faecal microbiota from children with kwashiorkor had a more profound weight loss than mice transplanted with microbiota from the twin without malnutrition, and this weight loss was associ ated with signs of disturbed metabolic pathways. In a separate birth cohort in Bangladesh, the presence of an immature faecal microbiota was linked with wasting 110 . Another study comparing the micro biomes between children with kwashiorkor and children with wasting found a moremodest difference in micro biome composition 111 . A potential limitation of study ing the microbiota in children with severe malnutrition is the use of antibiotic treatment before stool collection, which profoundly affects microbiota composition. Interest is growing regarding the interaction between the bacterial microbiome, the virome 112 and eukaryotic organisms, but the functional consequences of micro biota alter ations in children with severe malnutrition have yet to be well characterized.
Renal function. Studies assessing renal function (deter mined by glomerular filtration rate) in children with severe malnutrition have been limited. Given the fre quency of diarrhoea and dehydration in these children, the prerenal contribution to reduced glomerular fil tration might have a substantial role. Low glomeru lar filtration rates in children with malnutrition and dehydra tion have been reported 76 , and subsequent stud ies have reported impaired glomerular filtration rates and signs of tubular dysfunction with reduced urine osmolality, but the clinical relevance of low glomerular filtration remains unclear 113 .
Brain function.
Severe malnutrition is associated with acutely altered cerebral function and behavioural changes; children with kwashiorkor have cerebral atrophy 114, 115 and irritability, and children with severe wasting are often apathetic, with slowed movements and impaired speech. However, the underlying mechanisms of these behavioural changes are poorly understood. Although the association of severe malnutrition and growth in early life and development has been well docu mented, few studies have focused on longterm develop mental effects. Impaired development after an episode of severe malnutrition has been reported in children 116 , and psychosocial interventions have been shown to improve their development 117 . However, differing case definitions and treatment strategies make it challenging to disentangle the direct effects of severe malnutrition from the effects of other risk factors and adversities that these children typically experience. Additional studies are needed, particularly to understand the longterm effects on different domains of development. In contrast to severe malnutrition, the cognitive deficits associated with stunting are well described. Indeed, for every 10% increase in the prevalence of stunting, the proportion of children reaching the end of primary school has been estimated to drop by 7.9% 118, 119 .
Other pathophysiological alterations. Cellular Na + /K + ATPase pumps that maintain fluid, electrolyte and sub strate levels might be impaired in children with severe malnutrition. An increased membrane perme ability was found in leukocytes from children with kwashiorkor, and reduced Na + /K + ATPase activity has been observed in children with severe wasting, potentially as part of an adaptation to reduce energy expenditure 120, 121 . Figure 3 | Metabolic changes in severe malnutrition. Reduced secretion of insulin contributes to a catabolic state in both kwashiorkor (part a) and severe wasting (part b). In severe wasting, the reduced secretion of insulin leads to a lipolytic and proteolytic response and the release of free fatty acids (FFAs) and amino acids into the bloodstream. FFAs are taken up by muscle tissue for oxidation. Both FFAs and amino acids are also partially taken up by the liver and are used for ATP production and the synthesis of essential proteins and glucose. In kwashiorkor, this adaptive response is disturbed, which causes a reduced release of FFAs from adipose tissue and amino acids from muscle tissue. Mitochondrial damage in the liver is associated with increased reactive oxygen species (ROS) production and reduced glutathione. Arrow thickness represents the amount of metabolites in that pathway. TGs, triglycerides. Diagnosis, screening and prevention Diagnosis Although case definitions of severe malnutrition for epidemio logical, biological and clinical purposes focus on anthropometry 122 
, malnutrition is a functional problem and has been defined as a state resulting from lack of uptake or intake of nutrition leading to altered body composition, decreased body cell mass leading to diminished physical and mental function and impaired clinical outcome from disease 123 . Anthropometry is used to assess severe malnutrition because the functional deficits are difficult to measure directly. Anthropometry is therefore a proxy and not a direct measure of malnu trition. Importantly, no 'gold standard' measurement for the diagnosis of severe malnutrition exists. Different anthropometric measures assess different aspects and durations of the underlying functional deficit, and some relate more closely to body composition and clinical outcomes than others.
Anthropometry. The accepted diagnostic criteria for severe malnutrition have changed over time. Initially, the measurement of weightforage (that is, comparing the weight of the child with the weight of agematched chil dren in a reference population) was used, and severe mal nutrition was defined as <60% of the reference weight 124 . This definition was later refined with the addition of oedema as an additional criterion to diagnose kwashi orkor 30 . To focus on the highest risk group of the most acutely malnourished children rather than on those with a low weightforage who were mainly stunted, weight forheight was later used. Weightforheight compares the weight of the child to the weight of wellnourished children of the same height (length is used if children are <2 years old). The WHO recommended expressing meas urements as weightforheight Zscores (WHZs), that is, the number of standard deviations below or above the reference median value 125 . The main growth references that are used for the diagnosis of severe malnutrition are those derived from the 2006 WHO MultiCountry Growth Reference Study, which describes how children 'should' grow under optimal health, environmental and nutritional conditions 126 . Severe acute malnutrition is defined by the WHO as a WHZ of >3 standard deviations below the reference value for median weightforheight or the presence of bilateral pitting oedema 127 . Interestingly, a review of all studies on the relation ship between anthropometric indices and mortality concluded that WHZs are the least effective predictor of mortality 128 and that unadjusted midupper arm cir cumference (MUAC) was morediscriminatory for assessing mortality in several countries in Africa and Asia
129
. The association between MUAC and mortality might be due to the preferential selection of children who are younger, have both stunting and wasting and are particularly at risk 130 . A MUAC of <115 mm was introduced as an independent diagnostic criterion for severe acute malnutrition in children aged 6-59 months by the WHO in 2013 (REF. 131) 
. Although the use of MUAC for diagnosis is limited as this meas urement does not identify the same children with mal nutrition as WHZs 122 , following the development of community based management programmes that are effective in preventing malnutrition associated deaths, MUAC has been used more frequently. An alternative is to increase the MUAC cutoff value up to 120 mm to pragmatically define severe malnutrition. Although the additional children diagnosed with severe malnutrition on the basis of an increased MUAC value are not the same as those identified by WHZs, this approach can better identify children with a higher risk of death than an approach using both MUAC and a WHZ 
Identification of oedema.
Oedema is a sign of kwash iorkor and is assessed by pressing firmly down on the third to fourth tarsal bones on the dorsal aspect of the child's foot for 3-5 seconds and then looking for pitting oedema for 2-3 seconds. Oedema is graded according to the location on the body; grade 1+ indicates oedema limited to the feet and lower legs, 2+ indicates oedema that is present in the arms and grade 3+ indicates oedema of the face. The presence of symmetric, bilateral oedema of the feet in a vulnerable child in a highrisk population, regardless of the child's anthropometric measurements, is generally sufficient to diagnose kwashiorkor.
Infants <6 months of age. The diagnosis of severe mal nutrition in infants <6 months of age presents special challenges. These include the practical difficulties of undertaking anthropometric measurements on small infants 133 and that many individuals assume mal nutrition is rare at this age and so do not take measurements at all 134 . However, the burden of malnutrition in this age group is high 135 . The WHO currently recommends using a weightforlength Zscore (WLZ) of <−3 to identify infants with severe malnutrition, but only because of the paucity of evidence for other criteria. Few prospec tive studies have examined the discriminatory perfor mance of different anthropometric measures against the risk of death, but both weightforage and MUAC have been suggested for infants >60 days old 136 . Similar to what has been found in older children, MUAC identi fies a slightly different group of infants but has superior performance for predicting mortality than WLZs for populations in Gambia and Kenya 137, 138 . A MUAC of <110 mm for infants >60 days of age has been proposed based on a clinical trial in Kenya, which confirms that this measurement can identify infants with a very high risk of death 6, 138 .
Screening
In practice, given the challenges of measuring WHZs frequently or at a large scale in a community, screening programmes tend to use a MUAC of <115 mm to assess severe malnutrition in children 6 months to 5 years of age, and the assessment of oedema is used to diag nose kwashiorkor (FIG. 4) . Indeed, the best approach for screening for severe malnutrition is to measure MUAC frequently, ideally every month or every time a child is unwell. All anthropometric indices are better at identify ing highrisk children in the short term, that is, in the month following the measure 128 , and this applies to MUAC as well 139 . A promising approach to screening for severe malnutrition is to provide mothers with MUAC tapes that have a cutoff value of 115 mm and show them how to detect malnutrition using this measurement 6, 140 . This technique is simple enough to be taught rapidly 140 and enables malnutrition to be detected early (before the onset of complications), hence reducing the need for initial inpatient treatment 6 . However, the use of MUAC tapes to screen for severe malnutrition still has substantial room for global expansion, which has been delayed owing to the lack of guidelines, until recently, by normative bodies such as the WHO and UNICEF. This delay has contributed to the poor uptake of this practice by local practitioners and professional bodies.
Prevention
Given the high morbidity and mortality associated with severe malnutrition, preventing it is one of the most important goals in global health. Nevertheless, preven tion remains elusive in most impoverished and humani tarian settings, and it requires programmes that address maternal and child malnutrition holistically. Many countries have reduced the overall prevalence of severe malnutrition and stunting through the reduction of inequities [141] [142] [143] . In most instances, this achievement has required a combination of economic growth, the use of public sector programmes focused on reducing inequities and investments in nutritionsensitive (those that directly affect nutrition, such as breastfeeding and complemen tary feeding support programmes) and nutritionspecific (those that indirectly affect nutrition, such as improved agriculture and social safety nets) interventions. Indeed, no single intervention has effectively reduced the rates of severe malnutrition or stunting for individual chil dren 144, 145 , and packages of public health approaches are needed. These packages should include improved access to clean water, sanitation and hygiene, improved agricultural productivity to minimize food insecurity, timely universal vaccinations, early and efficient access to primary health facilities and care for acute illnesses (for example, pneumonia, diarrhoea, measles and malaria), an emphasis on exclusive and continued breastfeeding and attention to effective complementary feeding. Each approach is likely to affect malnutrition generally and, in turn, affect the rates of severe malnutrition 146 . 
Nature Reviews | Disease Primers
Despite several countries reducing the rates of mal nutrition in general, inconsistent effects of vertical pro grammes on childhood malnutrition have been reported. Indeed, the largest and most comprehensive multi centre trial testing the use of small quantities of lipid containing nutrient supplements did not show significant benefits regarding stunting or wasting in Malawi 147 and showed only modest benefits in Ghana 148, 149 . The same inter vention did have a better effect on stunting and wasting in Burkina Faso 150 , but notably, this trial also included treatment for diarrhoea and malaria. These data empha size the importance of interventions beyond nutritional therapy alone in atrisk populations.
At the level of the individual, a comprehensive pre vention package should begin with teenage girls and young women before pregnancy and should include comprehensive health education and the use of nutri tional interventions aimed at optimizing their overall physical health, nutritional status and psychosocial readiness for pregnancy and childbirth 151 . During preg nancy, women should be provided with evidencebased prenatal and perinatal support, including micro nutrient and macronutrient supplementation, treatment for infectious diseases (including prophylaxis and treatment for acute infections) and early and frequent education regarding neonatal nutrition and care 152 ; this strategy is believed to improve the health status of both the mother and the infant.
Optimizing macronutrient intake during infancy to prevent the development of severe malnutrition begins with the prompt initiation of breastfeeding, followed by exclusive breastfeeding for the first six months of life and the subsequent progressive introduction of nutri tious and diverse complementary foods, with continued breastfeeding for ≥2 years 153 . In addition, context specific micronutrient programmes can be used and might include vitamin A, iron, multiple micro nutrient powders or small quantities of lipidcontaining nutrient supplements. Additionally, zinc supplements can be used in children with acute diarrhoea. All children <5 years of age living in atrisk communities should undergo frequent growth monitoring, with the commencement of treatment for acute malnutrition when necessary. They should also receive all recommended immuniza tions and have ready access to essential interven tions and therapeutics when required (including oral rehydra tion salts for diarrhoea, antibiotics for pneumo nia and antimalarials, as well as antiretroviral therapy and opportunistic infection prophylaxis for children who have or have been exposed to HIV infection) 154 . Early and comprehensive intervention for children with moderate malnutrition is important for limiting the incidence of severe malnutrition as these children are assumed to have an increased risk of progression to severe malnutrition 155 .
Management
The goals of management of severe malnutrition are to prevent shortterm mortality, achieve sustained nutri tional recovery to reduce susceptibility to life threatening infections and to support neurocognitive development. Despite their striking clinical differences, the treatment recommendations for kwashiorkor and severe wasting have several common elements
The current management of severe malnutrition has evolved over several decades and is mostly based on expert opinion and a few observational studies and not on data from modern randomized clinical trials 156, 157 . Management is based on a series of WHO guidelines and training programmes, which are practical and have been widely adopted. Indeed, the management guidelines have become so engrained in clinical prac tice that it might be considered unethical to carry out randomized controlled trials except to show equivalence or superior ity to the current standard of care. Notably, many of the principles of management have emerged from emergencies, and translating these to lowincome and middle income countries, in which severe mal nutrition is a daily burden on health systems, remains a challenge 158 . In general, management includes the use of therapeutic foods along with antibiotics to treat any underlying infections. Management can be undertaken in communities for children with uncomplicated severe malnutrition (that is, children who are clinically stable and do not display clinical features of complications, especially coincidental infections).
Therapeutic foods
Therapeutic foods, such as readytouse therapeutic foods (RUTFs) and F75 and F100 milks, were designed for nutritional and metabolic stabilization and rehabili tation, and their use aims to address anticipated calor ific needs and treatment stageappropriate protein, electrolyte and micronutrient requirements, in addition to initially limiting exposure to nutrients that could be harmful to metabolically unstable children or those with infections, such as sodium and iron. However, the precise nutrient requirements of children with severe malnutrition and the bioavailability of these therapeutic foods are not well established and might vary by setting and the presence of comorbidities in some patients.
The formulations of F75 and F100 were derived and optimized based on metabolic studies of hospitalized children with severe malnutrition, with the aim of prov iding the micronutrients and macronutrients that are likely to be deficient in a child with severe malnutrition. F75 is used for initial refeeding and F100 is effective in facilitating rapid catchup weight gain but might not correct all of the metabolic disturbances in children with severe malnutrition. RUTFs were developed to contain the same nutri tional content as the F100 therapeutic milk formula but in a dehydrated form that can be administered in the home environment with no preparation or cooking required and minimal risk of contamination 159 . RUTFs have no mandatory formulation but do have minimum micronutrient and macronutrient concentrations and quality control and microbiological safety standards, which are outlined by WHO and UNICEF 160 . The pre dominant formulation of RUTFs consists of peanut paste, milk powder, sugar, oil and micronutrients. The high cost of RUTFs is largely due to their milk powder component, which might be only partially overcome by using local production methods as this is also associated with high costs, including the costs of constructing and maintaining appropriate produc tion facilities and importing ingredients, as well as high local taxes. Trials investigating the use of RUTFs with out milk powder have suggested an inferior effect on child growth 161, 162 . The essential polyunsaturated fatty acid (PUFA) composition of RUTFs is not optimal 8, 163 , but a morefavourable composition, such as a reduced ω6 PUFA content or increased longchain ω3 PUFA content, presents challenges for shelf life; the effects of these compositions on growth and neurodevelopment are uncertain.
As RUTFs provide individuals with nutrients at levels that are nearly impossible to reach without supplemen tation 164 , the direct assessment of the effect of RUTFs on weight gain compared with the effect of a local diet alone has not been carried out. However, children treated with RUTFs have a higher proportion of recovery and weight gain than children who received a local diet supplemented with additional vitamins and minerals 7, 165 . Despite the benefits associated with use of thera peutics foods, a rapid increase in macronutrient and micronutrient intake can lead to some negative health consequences, including diarrhoea (due to carbohydrate malabsorption) 166, 167 and refeeding syndrome
. The risk of refeeding syndrome might be reduced when children consume therapeutic foods on demand based on their appetite rather than being forcefed using a naso gastric tube 168, 169 . However, no randomized trials testing the formulations, amounts or durations of feeding of F75 or F100 have been published.
Antibiotics
Current guidelines recommend empiric antibiotics for all children with severe malnutrition because of con cerns that although some children might not initially present with signs of infection, they might deteriorate suddenly without fever or other warning signs 170, 171 . No prospective clinical trials showing the need for anti biotics in children with complicated severe mal nutrition have been published. However, there are reports of in vitro nonsusceptibility to βlactam antibiotics and gentamicin, the recommended firstline agents, although the implications of these findings in terms of outcomes have yet to be tested in clinical trials. Interpreting the results of these studies is challenging owing to biases; these studies are usually conducted in tertiary centres and/or do not distinguish communityacquired from hospitalacquired infections 172 . For outpatient management of children with uncompli cated, severe malnutrition, the use of routine antibiotic therapy has been questioned because of the cost and the risk of enhancing antimicrobial resistance. In one study in Malawi, children with severe mal nutrition receiving amoxicillin or cefdinir had 36% and 44% reductions in mortality, respectively, and they had faster recoveries than children who received placebo 5 . Of note, this area had a high prevalence of kwashiorkor compared with other centres. In another study in Niger, mortality was unchanged in children with uncomplicated severe wasting who had not been previously treated for malnutrition and who were given oral amoxi cillin compared with placebo in an out patient feeding programme attached to a referral hospital 173 . However, amoxicillin treatment was associ ated with a faster recovery and a 14% reduction in the proportion of children who were referred to hospital in another study 173 . Collectively, evidence from these trials supports the use of empiric antibiotics in outpatient manage ment 172, 174 , although further research on other types and severities of malnutrition, other care settings, the effects on antimicrobial resistance, the potential use of pointofcare biomarkers and costs are needed.
Box 4 | Refeeding syndrome
Refeeding syndrome can contribute to poor clinical outcomes in children with severe malnutrition. Rapidly increased nutrient intake can cause a switch from a catabolic to an anabolic state, which can lead to a surge in insulin secretion, acute hypoglycaemia and the transport of extracellular electrolytes into cells. This electrolyte flux can lead to dangerously low blood concentrations of potassium, magnesium and phosphate, which can result in lethargy, seizures, muscle weakness, impaired cardiac function and respiratory failure 225 . The precise incidence of refeeding syndrome is unknown, which is related to the lack of a precise definition and the fact that, in most settings, the accurate measurement of electrolytes and other biomarkers cannot be carried out. In addition, insufficient intake of electrolytes and their loss through the gastrointestinal and renal systems can affect electrolyte concentrations, making it challenging to relate abnormal plasma levels to refeeding syndrome. A recent study in Uganda reported hypophosphataemia in 76% of children with severe malnutrition 2 days after admission, which was associated with mortality 168 . Interestingly, refeeding syndrome influenced the development of the main milk-based refeeding formulation used for the stabilization of patients (F-75), which is characterized by a low protein content and reduced energy content (mostly from carbohydrates) compared with F-100, and contains phosphate, potassium, magnesium, vitamin A and zinc, among other micronutrients. However, as F-75 provides individuals with an energy source that is mostly from carbohydrates, this leads to increased glucose levels and, potentially, a surge in insulin secretion and a high demand for phosphorylated glycolytic intermediates, which could precipitate severe hypophosphataemia. Whether reducing calorie intake or energy from carbohydrates during the initial hospitalization of patients with severe malnutrition would reduce the incidence and severity of refeeding syndrome is currently unknown.
Other interventions
Profuse watery diarrhoea, hypovolaemia and shock are common in children with severe malnutrition and are associated with high mortality, despite current manage ment guidelines 99, 175 . The optimal composition and rate of administration of intravenous or oral fluid therapy, or other supportive therapies, in settings that do not have access to advanced paediatric intensive care is unclear and controversial 176 as only two small trials have been con ducted to study individuals with severe mal nutrition 177, 178 . Another large trial indicated that aggressive fluid manage ment in children without severe malnutrition and diarrhoea, but with some signs of shock, is harm ful 179 , which is likely to be the case in children with mal nutrition. Studies that distinguish shock caused by sepsis from hypovolaemia caused by diarrhoea in children with severe malnutrition have not been carried out, but they are needed to inform management strategies that could be implemented in hospital settings.
Other features of severe malnutrition include chronic systemic and intestinal inflammation, infection and environ mental enteric dysfunction (that is, inflammation, reduced absorption and reduced barrier function in the small intestine) 49 . Mortality risk is more closely related to markers of systemic rather than intestinal inflam mation 102 , although bacterial intestinal translocation and aberrant immune function might contribute to both systemic and intestinal inflammation. Trials assessing the use of oral prebiotics or probiotics among children with severe malnutrition have not shown effects on inpatient mortality outcomes, but they do suggest subsequent bene fits for growth 9, 180 , and in the future, the use of prebiotics and probiotics are likely to be better directed by improved knowledge of microbiota ontogeny and function 112, 181 . Gutprotective therapies targeting inflammation, micro bial translocation, malabsorption, intraluminal nutrient processing and normalization of the intestinal micro biota might yield novel and effective interventions. Other potential strategies for reducing malnutrition associated mortality and improving growth include the use of antiinflammatory agents 182 and guttrophic nutrients, including alanylglutamine 176, 183 and other dipeptides.
Uncomplicated severe malnutrition
Until the 2000s, all children with severe malnutrition were usually managed as inpatients with milkbased therapeutic foods and empiric broadspectrum paren teral antibiotics, which assumed that these patients always had nutritional and metabolic complications and serious, subpatent infections 127 . However, management has been revolutionized by the detection of children with uncomplicated malnutrition, who can be safely treated in the community via a proactive, public healthbased approach to care. This is made possible by community screening that uses MUAC assessments and by feeding children a RUTF at a dose of 175 kcal/kg per day 129, 184 . The effectiveness of RUTFs in decreasing the mor tality of children with severe malnutrition cannot be overstated. Early RUTF trials reported a lower mortal ity for children treated with RUTFs in their community than for those previously treated in hospitals. Following these trials, community treatment programmes rapidly expanded, which dramatically improved treatment cover age to reach previously untreated children. Following from this, many communitybased programmes have shown lower mortality rates compared with historical data for hospitalbased treatment outcomes. Accordingly, the development of communitybased programmes has largely occurred in the absence of formal randomized controlled trials (comparing children treated with RUTFs with untreated children), as carrying out these trials would be unethical. For the same reasons, the effective ness of hospitalbased treatment in reducing mortality has never been formally established.
Decentralized services closer to patients' homes can avoid the costs and risks of inpatient care, including nosocomial infections 185, 186 , and has enabled uncompli cated severe malnutrition (generally >90% of all children with severe malnutrition) to be treated in the commu nity 184 (FIG. 5) . Outcomes of children with uncompli cated severe malnutrition treated in their community are markedly better than of children with complicated malnutrition of similar anthropometric status 187, 188 .
Complicated severe malnutrition
Children with complicated severe malnutrition (that is, children with a moresevere disease who are sick) are managed as inpatients so that lifethreatening complications (such as infections) can be addressed along with nutritional and metabolic deficits. The aim of nutritional management is to address disturbed carbo hydrate and energy metabolism, which affects blood glu cose levels and body temperature regulation 67, 189 , as well as the distribution of fluid and electrolytes. Regular feeding with, initially, less energydense food aims to pre vent and treat hypoglycaemia, reduce sodium levels, and increase potassium and phosphate levels. The adminis tration of hyperosmolar and intravenous fluids is avoided whenever possible 190 . Therapeutic feeding is cautiously started with milk based food (specifically, 130 ml/kg per day of F75, which provides 97.5 kcal/kg per day) that initially con tain low levels of protein and sodium and high levels of potassium, which is designed to match the child's reduced metabolic capacity. Initial feeding aims to improve metabolism, gut motility and nutrient absorp tion, and clinical improvements during this phase manifest as improved appetite and reduced oedema (if present). When appetite is restored and the signs of infectious complications improve, children transition to RUTFs or milkbased foods with higher energy and protein levels (such as F100 at 130-200 ml/kg per day which provides 130-200 kcal/kg per day) to gain weight. No other food should be given, with the exception of breast milk, which should be given before therapeutic foods are administered to keep stimulating the maternal milk supply. Additional micronutrients (such as zinc for diarrhoea) beyond what are included in the therapeutic food are generally unnecessary without specific signs of a deficiency 190 .
Under current WHO recommendations, children are discharged from inpatient care when their serious complications have resolved rather than after they have met specific anthropometric targets, and they continue therapeutic feeding and supplementary feeding (for moderate malnutrition) as outpatients 151 (FIG. 6) . The transition of patients from the hospital setting to home requires ensuring that the parent or caregiver under stands the treatment phases and what is expected from them in addition to enrolling them in available nutri tional, medical and social services.
Children with complicated severe malnutrition are usually admitted to hospital because of severe infections and typically have a fatality rate of 12% to >20% 168, 191 . HIV infection is present in 15-29% of children hospitalized with severe malnutrition in SubSaharan Africa and is associated with a threefold increased risk of inpatient mortality 168, 192, 193 . Studies aiming to reduce mortality in children with complicated severe malnutrition have included increased nursing support, systematic feeding or reductions in intra venous fluid administration and have been met with limited success [194] [195] [196] , presenting a clear need for research to improve care 22, 176 .
Infants <6 months of age Infants <6 months of age with severe malnutrition are fed with breast milk and infant formula, or diluted F100 milk, often by using a technique called 'supple mentary suckling' . A key aim of treatment is to estab lish or re establish effective exclusive breastfeeding wherever possible. These infants also receive empiric antibiotics 134 . Further research is needed to determine the efficacy of this strategy and other components of the management of these infants 197 . Nature Reviews | Disease Primers Nutritional support focuses first on helping to restore physiological processes to a normal state and then on achieving rehabilitation. Initially, use of the 'ABCD' mnemonic can help focus attention on the assessment and maintenance of the airway (A) and breathing (B), circulation (C) and disability (coma, convulsion and dehydration (D)). Children with complicated severe malnutrition remain exceptionally vulnerable during treatment and can deteriorate rapidly without clear prior warning signs. Accordingly, monitoring and frequent re-evaluation are essential. When prevalent, comorbidities such as tuberculosis and HIV should be actively tested for. If community-based management of uncomplicated severe malnutrition is available, the decision to discharge children from hospital is based on their appetite and the resolution of complications rather than on anthropometric parameters, and should be decided by nutritional and clinical staff. The treatment process in hospital and after discharge should be explained to parents and caregivers, and they should know what help is available to them and what is expected of them. RUTFs, ready-to-use therapeutic foods.
Quality of life
Children with severe malnutrition typically live in set tings of pervasive poverty, low female literacy, food insecurity, inadequate water and sanitation and over stretched health systems 198 . Acute management inter ventions for the treatment of severe malnutrition do not fundamentally alter these underlying risks. Most chil dren with acute malnutrition are also severely stunted at presentation 7, 173 , which indicates that they have chronic ill health and malnutrition. Several studies in Malawi, Kenya, Gambia and Bangladesh have shown that anthro pometric recovery is not sufficient as children have a high rate of death following discharge from inpatient care for severe malnutrition, predominantly from pneumonia and diarrhoea 6, 199 . In addition, mortality is increased in children following treatment in communitybased nutrition programmes 184, 200 . The reasons for this likely contains a home environment that includes risk factors for malnutrition, an undiagnosed chronic illness and that attending health care visits for episodes of illness or ongoing therapeutic feeding might be limited in certain areas 200, 201 . In addition, some children with severe mal nutrition might have a preexisting vulnerability (such as a mild immune deficit that would cause minimal health problems in a resourcerich setting with a low prevalence of infectious diseases) that results in a cycle of illness and malnutrition and a high degree of vulner ability to infection 202 . Certainly, not all siblings who grow up in the same family are equally affected by the same home environment 203 . During treatment and recovery from severe mal nutrition, weight and MUAC usually increase rapidly, but height does not, and growth is typically sufficient only to reach the baseline heightforage Zscore 173, 203 . Children who have been treated for severe malnutrition typically have less lean mass (that is, fatfree mass) than children without malnutrition in the same community 162, 204, 205 . Indeed, children in Malawi had lower lean tissue and were more severely stunted at an average of 7 years after hospitalization for severe malnutrition, than controls, but had a similar head circumference and respiratory and cardiometabolic function 204 . In addition, children with prior severe malnutrition have weaker hand grip and lower exercise tolerance than children who have not had malnutrition 204, 206 . This 'thrifty' growth pattern indicates that severe malnutrition in early childhood might predis pose an individual to noncommunicable diseases later in life. However, this predisposition is difficult to assess as stunting and other insults might have been present before severe malnutrition developed in the children enrolled in these studies. Although the effect of in utero exposure to malnutrition and its risk factors leading to a wide range of noncommunicable diseases later in life is estab lished 207, 208 , the critical window or risk for these effects and the consequent effect of infant and child malnutrition on noncommunicable diseases later in life is still unclear 209 . Severe malnutrition and stunting are associated with delayed child neurodevelopment, behavioural problems, lower school achievement and reduced adult earning potential 2, 210 . The use of psychosocial stimulation, such as play and giving positive feedback training to mothers or prolonged home visiting programmes after infants or young children with severe wasting or kwashiorkor have been discharged from the hospital, has been shown to significantly improve infant development scores in the short term, as well as educational achievement and IQ into adolescence 116, 211, 212 . Several micronutrients are potentially essential for cognitive development, including PUFAs, thiamine, choline, vitamin D, folate, iron, copper, selenium and iodine 213 , and deficiencies in these might vary among children with severe malnutrition according to the child's age, location and the cause of malnutrition. However, supplementation with these micronutrients has not undergone clinical trials with neurodevelopmental end points in the context of severe malnutrition.
Further studies are needed to assess the optimal dur ation of treatment with therapeutic foods, factors limit ing lean (muscle, organ and connective) tissue synthesis (including the role of highquality dietary protein), how zinc and other micronutrients can modulate lean tissue deposition, the benefits of psychosocial stimulation and physical activity and the longterm effects of malnutrition on health risks in adolescence and adulthood 204 .
Outlook
Although this Primer has highlighted many of the neg ative consequences of severe malnutrition, it is impor tant to note that our understanding of the epidemiology and management of severe malnutrition has improved. Indeed, communitybased management of severe mal nutrition has revolutionized treatment programmes and has enabled large numbers of children to receive effective nutritional and clinical care in various settings. Children with severe malnutrition and a high risk of death can be easily identified, and many of them can be successfully • Determining the burden of severe malnutrition based on its incidence • Determining the causes of death associated with malnutrition, including infection and impaired energy metabolism • Determining the pathophysiology of kwashiorkor and its implications for management • Determining the mechanisms of functional immune impairment and the association with nutritional rehabilitation • Determining the long-term effect on body composition, metabolism and neurodevelopment of severe malnutrition and its treatment, with or without preterm and/or low birth rates • Devising preventive strategies that work on a large scale and are low in cost • Developing strategies for the integration of protocols to prevent severe malnutrition in fragile and humanitarian settings • Improving the management of acute malnutrition in infants <6 months of age 197 • Improving risk stratification to help identify which patients need inpatient care and those that need empiric antimicrobials, and determining which antimicrobials should be used • Simplifying treatment protocols and developing protocols that can be used at the community level with minimal supervision • Developing new formulations of ready-to-use therapeutic foods that optimize several nutritional parameters to maximize patient survival, weight gain, correction of metabolic perturbations, and long-term cognitive, physical and immunological development treated at the community level by parents with assis tance from community health workers, in addition to outreach services. The use of appropriate prevention and manage ment interventions for severe malnutrition could pre vent 61% of cases of wasting and almost 350,000 child deaths annually 214 , and several major international initi atives, such as No Wasted Lives 215 , are working towards ambitious targets to achieve this. Although progress towards lowering childhood mortality is ongoing, more work is still required. Indeed, as more children sur vive episodes of severe malnutrition, and as poverty decreases in many countries, new challenges will emerge. For example, helping children to survive an episode of severe malnutrition is no longer enough. Following the Global Strategy for Women's, Children's and Adolescents' Health (2016-2030), we must also help these children to thrive 214 . To do this, curative and preventive services must be transformed. More effort is needed in previously neglected populations, such as infants <6 months of age 216 and children with underlying disabilities 217 and other identi fied vulnerabilities. In addition, focus is needed on the prevention of relapse and readmission, although how this can be achieved is uncertain. One large trial investigating the use of prophylactic cotrimoxazole for highrisk children following discharge from hospital in Kenya showed negative results for reducing the risk of relapse and death 6 . However, other broadspectrum anti biotics or other therapies that could support a prolonged period of immune system recovery might be beneficial. In addition, improved social support and social safety nets to address food security are other areas to explore. Other research gaps regarding severe malnutrition are described in BOX 5 (REFS 218, 219 ).
An improved understanding of several areas of the pathophysiology of severe malnutrition and the effi cacy of potential interventions might be able to save the lives of these highrisk children. For example, under standing the pathophysiology of kwashiorkor could lead to phenotype specific therapeutic interventions; this requires research that uses modern tools for assessing metabolism and other physiological functions. In addi tion, although much of the previous research on the pathophysiology of severe malnutrition has been inform ative and hypothesisgenerating, the research does not commonly meet today's standards for quality in terms of participant selection, the avoidance of bias and sample size. Going forward, the testing of wellfounded hypoth eses in appropriately designed randomized trials with the use of biomarkers, information on mechanisms and sound clinical measures is required.
The overarching priority is to make severe malnutri tion a thing of the past in countries in Africa and Asia, as is the case in Europe and North America today. Achieving the SDGs for health and nutrition will be possible only through addressing severe malnutrition, and to do this, we must recognize that reducing the burden of morbidity and mortality associated with severe childhood malnutri tion is a global moral imperative. To eradicate severe mal nutrition will require political will, investment in peace building and reducing manmade and natural disasters, which are issues that should unite the world.
